Clinical Trial

A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer

Name: A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer — clinical trial record (NCT06746298)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated December 24, 2024 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.

Summary

This is a prospective study of expression profiling-based assessment of the efficacy of neoadjuvant therapy for rectal cancer.

Trial Details

NCT Number	NCT06746298
Lead Sponsor	Shanghai Minimally Invasive Surgery Center
Conditions	Rectal Cancer, Neoadjuvant Therapy
Enrollment	118 participants
Start Date	2025-01-01
Primary Completion	2026-05-31 (estimated)
Study Completion	2027-05-31 (estimated)
Updated on ClinicalTrials.gov	2024-12-24